CITIC Construction Investment: The pharmacy industry is currently recovering moderately, and transformation is expected to catalyze valuation enhancement

CITIC Construction Investment released a research report indicating that the pharmacy industry is experiencing a mild recovery, while traditional pharmacies face development pain points, making differentiated transformation imperative. The industry needs to adapt to the economic environment, policy changes, and consumer habits, differentiating into specialized and diversified pharmacies. Specialized pharmacies meet the needs of patients discharged from hospitals, while diversified pharmacies focus on daily health needs. Compared to Japan, pharmacy companies need to leverage policy support to promote differentiated development in order to gain additional growth

JZJ: The shareholding ratio of the actual controller and controlling shareholder has increased to 40.7056%

JZJ announced that the shareholding ratio of the actual controllers, Mr. Lan Bo and Ms. Shu Chang, has increased from 40.6787% to 40.7056%. This change in equity is due to the appointment of senior management by three partnership enterprises, resulting in the executives and the partnership enterprises being deemed as acting in concert, forming a concerted action relationship with the actual controllers, leading to a total increase in shareholding ratio of 0.0269%. This change does not trigger a tender offer and will not result in a change in the actual controllers and controlling shareholders of the company

China Post Securities: The retail pharmacy industry continues to clear out, and the ongoing coordination is expected to bring performance growth

China Post Securities released a research report indicating that the retail pharmacy industry is accelerating its clearance, with the number of closed pharmacies reaching 39,228 in 2024. It is expected that after industry consolidation, leading pharmacies will see a recovery in customer traffic. Leading pharmacies, leveraging their first-mover advantage in outpatient management, will attract more customers, enhance medical insurance consumption and related product consumption, thereby increasing the average transaction value and performance. Policy-driven prescription outflow and the trend of incorporating retail pharmacies into medical insurance management will further promote industry development

Pharmaceutical commercial stocks opened strong, with YIXINTANG hitting the limit up, Hezong Medicine Easy-To-Buy Pharmaceutical rising over 10%, and JZJ, Saili Medical, Huaren Health, SYPM, and others following suit

Zhitong A-share lock-up release overview | April 29

On April 29th, a total of 10 listed companies had their restricted shares unlocked, with a total market value of approximately 6.016 billion yuan. The specific situation of the restricted shares unlocked today is as follows: Stock Abbreviation Stock Code Type of Restricted Shares Number of Shares Unlocked Jiuzhou Pharma 603456 Equity Incentive Restricted Circulation 480,900 Soling 002766 Equity Incentive Restricted Circulation 3.31 million JiangSu Suyan Jingshen 603299 Equity Incentive Restricted Circulation 3.3273 million Xiang Oil Pump 603319 Equity Incentive Restricted Circulation 326,900 JZJ 605266 Additional A Shares Legal Person Allocation Listed 11.5152 million WanNeng RiXin 301162 Pre-issuance Shares Restricted Circulation 35.4344 million Yongtaiyun 001228 Pre-issuance Shares Restricted Circulation 49 million Worldia 688028 7.5767 million Delong Laser 688170 23.74 million Jingye Intelligent 688290 41.36 million